Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.

AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...